4LSC2025 Macimorelin acetate CAS# 945212-59-9

Catalog Number: 4LSC2025
CAS #: 945212-59-9 (acetate salt)
Related CAS # 381231-18-1 (free base)
Name: Macimorelin acetate, Macrilen, ARD-07, AEZS-130, JMV1843, 2-amino-N-((R)-1-(((R)-1-formamido-2-(1H-indol-3-yl)ethyl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-2-methylpropanamide acetate

 In Stock

Macimorelin acetate (Macrilen) is a Growth Hormone Secretagogue (GHS) causing the release of Growth Hormone (GH) from the pituitary gland. It became the first EMEA (2019) and FDA (2017) approved GHS to diagnose Adult GH Deficiency (AGHD).  Macimorelin boasts an oral formulation for ease of administration for patients and providers.   Macimorelin is a mimic of ghrelin, a growth hormone secretagogue (GHS or GHRP). It binds to the growth hormone secretagogue receptor (GHSR) causing release of growth hormone from the pituitary gland.

Keywords & field of application:

Diagnostic tools, biochemicals probes, new formulation development, drug repurposing, anti-doping control.

For Macimorelin synthesis intermediates and impurities please contact us!

  • Molecular Formula: C28H34N6O5 (acetate salt), C26H30N6O3 (free base)
    Molecular Weight: 534.62 g/mol (acetate salt), 474.57 g/mol (free base)
  • Specification: Minimum purity: 95.0 %
  • Packing Size: 5mg, 10mg, 100mg, bulk (gram scale)
  • Solubility: methanol, water, acetonitrile
  • Physical Appearance: white solid
  • Storage: 4°C (long term storage)
  • HS Code: 284590

Macimorelin as a Diagnostic Test for Adult GH Deficiency. Garcia et al. 2018, J. Clin. Endocrinol . Metab. , 103(8):3083-3093. doi: 10.1210/jc.2018-00665


You may also be interested in the following product: